GGiantBullStocks

Catheter Precision, Inc. (VTAK)

AMEX · Healthcare

$0.50-10.36%

As of Jul 20, 2026

Price history

Key statistics

Market cap
$1.48M
P/E ratio
EPS
Volume
2,508,227
52-week high
52-week low
Open
$0.52
Day high
$0.53
Day low
$0.31

Financial highlights

Fiscal yearRevenueNet incomeEPS
2025$819K-$17.18M-$15.90
2024$420K-$16.64M-$126.91
2023$442K-$70.57M-$129.88
2022$14K-$26.87M-$25.98
2021$22K-$25.07M-$248.22

About Catheter Precision, Inc.

Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.

CEO
David A. Jenkins
Employees
17
Country
US
IPO date
Sep 27, 2018

Similar stocks

Other Healthcare companies

Frequently asked questions

What is Catheter Precision, Inc.'s stock price today?
VTAK is trading at $0.50 as of Jul 20, 2026.
What is Catheter Precision, Inc.'s market cap?
Catheter Precision, Inc. (VTAK) has a market capitalization of $1.48M.
Does Catheter Precision, Inc. pay a dividend?
Catheter Precision, Inc. did not pay a dividend in its most recent reported fiscal year.
What sector is Catheter Precision, Inc. in?
Catheter Precision, Inc. operates in the Healthcare sector.